Association with Aurora-A Controls N-MYC-Dependent Promoter Escape and Pause Release of RNA Polymerase II during the Cell Cycle.

TitleAssociation with Aurora-A Controls N-MYC-Dependent Promoter Escape and Pause Release of RNA Polymerase II during the Cell Cycle.
Publication TypeJournal Article
Year of Publication2017
AuthorsBüchel G, Carstensen A, Mak K-Y, Roeschert I, Leen E, Sumara O, Hofstetter J, Herold S, Kalb J, Baluapuri A, Poon E, Kwok C, Chesler L, Maric HMichael, Rickman DS, Wolf E, Bayliss R, Walz S, Eilers M
JournalCell Rep
Volume21
Issue12
Pagination3483-3497
Date Published2017 Dec 19
ISSN2211-1247
KeywordsAurora Kinase A, Cell Line, Tumor, DNA Topoisomerases, Type II, DNA, Intergenic, Humans, N-Myc Proto-Oncogene Protein, Nuclear Proteins, Phosphoproteins, Promoter Regions, Genetic, Protein Binding, RNA Polymerase II, S Phase, Transcription Elongation, Genetic, Transcription Factors, TFIII
Abstract

MYC proteins bind globally to active promoters and promote transcriptional elongation by RNA polymerase II (Pol II). To identify effector proteins that mediate this function, we performed mass spectrometry on N-MYC complexes in neuroblastoma cells. The analysis shows that N-MYC forms complexes with TFIIIC, TOP2A, and RAD21, a subunit of cohesin. N-MYC and TFIIIC bind to overlapping sites in thousands of Pol II promoters and intergenic regions. TFIIIC promotes association of RAD21 with N-MYC target sites and is required for N-MYC-dependent promoter escape and pause release of Pol II. Aurora-A competes with binding of TFIIIC and RAD21 to N-MYC in vitro and antagonizes association of TOP2A, TFIIIC, and RAD21 with N-MYC during S phase, blocking N-MYC-dependent release of Pol II from the promoter. Inhibition of Aurora-A in S phase restores RAD21 and TFIIIC binding to chromatin and partially restores N-MYC-dependent transcriptional elongation. We propose that complex formation with Aurora-A controls N-MYC function during the cell cycle.

DOI10.1016/j.celrep.2017.11.090
Alternate JournalCell Rep
PubMed ID29262328
PubMed Central IDPMC5746598